cimed industria de medicamentos ltda.

What cimed industria de medicamentos ltda. does

Cimed Industria de Medicamentos Ltda. (operating as Grupo Cimed, legal entity CIMED & CO. S.A.) is a privately held Brazilian pharmaceutical company founded in 1977 and headquartered in São Paulo, with manufacturing concentrated in Pouso Alegre, Minas Gerais. The company develops, manufactures, and distributes a portfolio of more than 600 products across four categories — prescription and OTC medicines, vitamins and supplements, personal care and beauty, and dermocosmetics — sold through more than 80,000 retail points representing roughly 90% of Brazilian pharmacies, supported by 26+ distribution centers and a direct field sales force of more than 800 representatives. The company is the 3rd or 4th largest pharmaceutical company in Brazil by sales volume, generating R$3 billion in revenue in 2023 (up from R$1.9 billion in 2022) with a stated target of R$5 billion by 2025. Sub-brands include Carmed (lip moisturizer, ~R$400 million in 2023 revenue), Lavitan (vitamins), K-MED (~60% share of Brazil's intimate lubricant category), Cimegripe, Nevralgex, Bepantriz, and Acnezil.

The company operates a vertically integrated production model spanning raw materials to finished pharmacy-ready products, underpinned by the Instituto Claudia Marques de Pesquisa e Desenvolvimento (ICM P&D) — an in-house bioequivalence center used both internally and by competitors — and a modern Pouso Alegre manufacturing complex whose newest unit doubles production capacity by 2025. Annual R&D investment exceeds R$90 million, and the company has conducted pioneering protein-crystallization experiments aboard the International Space Station through the CimedX project in partnership with Airvantis and CNPEM. Go-to-market combines a sales-led pharmacy channel with sports-driven brand-building (official CBF national-team sponsor since 2015, Cruzeiro sponsor through 2026), influencer and co-branding campaigns (Mattel/Barbie, Fini, Burger King), and growing e-commerce via lavitan5g.com.br and major pharmacy platforms. Founder João Adibe Marques remains President and primary controller.

Name

cimed industria de medicamentos ltda.

Legal name

CIMED & CO. S.A.

Website

https://grupocimed.com.br

Company type

Private

Founded year

1977

Operating status

Operating

Short description

Cimed is a privately held Brazilian pharmaceutical company that manufactures and distributes more than 600 medicines, vitamins, personal care, and dermocosmetic products through 80,000+ pharmacy points nationwide, targeting all consumer segments across Brazil.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

Multivitamins & Daily Packs (CRADAGAC), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE), Beauty-From-Within (Collagen, Biotin, Skin/Hair/Nails) (CRADAGAH)

Keywords

• Pharmaceutical manufacturing
• Generic and over-the-counter medicines
• Vitamins and supplements
• Personal care products
• Dermocosmetic products

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices6 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Products: Cimed generates primary revenue through the manufacture and sale of pharmaceutical products including prescription medicines, OTC medications, and generic drugs. The company offers over 600 products across multiple therapeutic categories.
2. Vitamins and Supplements: Revenue from vitamins, supplements, and nutritional products including the Lavitan brand which is positioned as a sports vitamin line.
3. Personal Care and Beauty Products: Hygiene, beauty, and personal care products including the successful Carmed lip moisturizer line, Acnezil acne products, and intimate care products like K-MED lubricants.
4. Dermocosmetics: Revenue from dermatological cosmetic products for daily skin care, positioned as accessible high-quality products.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

Cimed develops, manufactures, and sells prescription and over-the-counter medicines, generic drugs, vitamins, supplements, personal-care and beauty products, and dermocosmetics. Its portfolio contains more than 600 products, supported by vertically integrated production, an in-house bioequivalence center, and dedicated research and development operations.

Product overview

Cimed is a Brazilian pharmaceutical company with a vertically integrated business model offering a diversified portfolio of over 600 products. The portfolio comprises four main categories: Medicines (OTC and generic medications including Cimegripe, Nevralgex, Fexx, and generic drugs), Personal Care and Beauty (including intimate lubricants K-MED with 60% category market share, oral care Ciflogex, baby care João e Maria, and insect repellent Xô Inseto!), Vitamins and Nutrition (Lavitan multivitamins and supplements including sports formulations), and Dermocosmetics (Bepantriz, Dermafeme, Acnezil acne treatment line). Key brand extensions include Carmed lip moisturizer which achieved viral success through Fini collaboration and has been expanded with Barbie and celebrity partnerships, and Ressaliv hangover relief line launched in 2024 with innovative carbonated isotonic format. The company also operates a bioequivalence center (Instituto Claudia Marques de Pesquisa e Desenvolvimento) for R&D and maintains ISO 14001 environmental certification.

Differentiator

Problem solved

Functional benefit

Brands

• Carmed: Lip moisturizer brand - market leader in Brazil with approximately 60% market share
• Lavitan
• K-MED
• Cimegripe
• Nevralgex
• Xô Inseto!
• Bepantriz
• Dermafeme
• Ressaliv
• Acnezil
• Fexx
• Ciflogex
• Genéricos Cimed
• João e Maria
• Milimetric

Products and services

• Carmed Lip-moisturizer brand offered in multiple variants and co-branded collections.
• Lavitan Vitamin and supplement line offering multivitamins, targeted hair and beard formulations, and sports-related products.
• Cimegripe Over-the-counter medication line for flu and cold symptoms.
• Bepantriz Dermatological product line for skin care and healing.
• Nevralgex Medication product for neurological pain conditions.
• Xô Inseto! Insect-repellent product line for personal protection.
• K-MED Intimate-lubricant brand with warming and ice variants and approximately 60% category market share.
• Ciflogex Oral-care and hygiene product line.
• Fexx Antihistamine medication providing 24-hour allergy control.
• João e Maria Baby-care product line covering hygiene and personal care.
• Acnezil Acne-treatment line including drying gel, liquid facial soap, bar soap, FPS30 sunscreen, and benzoyl peroxide gel 5%.
• Dermafeme Dermatological feminine-care product line.
• Ressaliv Hangover-relief, hydration, and recovery line including Pré supplements, carbonated isotonic drinks, and Dor analgesic.
• Genéricos Cimed Generic-medication line positioned at accessible prices and packaged with larger lettering and dosage-information space.
• Carmed Barbie Collection Limited Carmed lip-moisturizer collection offered in Pink, Rose Gold, and Crystal variants.
• K Med Ice 200g 200g version of the K Med Ice intimate lubricant.
• Lavitan Cabelos e Barba Corleone Lavitan vitamin developed for hair and beard use in partnership with Barbearia Corleone.

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered flagship, core and minor.

• Confederação Brasileira de Futebol (CBF)flagshipGTM or Marketing PartnerCimed is the official sponsor of all Brazilian National Football Teams (men's and women's) since 2015. The partnership was renewed in March 2024 for the new World Cup cycle. The company gains extensive brand visibility through team jersey placements, LED boards at games, and product activations. Includes collaboration on special edition products like Carmed Canarinho lip moisturizer.
• Cruzeiro Esporte ClubecoreGTM or Marketing PartnerSponsorship contract until end of 2026 covering both men's and women's football. Cimed provides vitamins and supplementation to athletes at no cost. Brand appears on main jersey of women's team, goalkeeper and coaching staff uniforms of men's team, captain's armband, and digital assets including mini documentaries.
• Viação Cometa (Grupo JCA)coreGTM or Marketing PartnerPartnership for 'Carmed com Cometa na Estrada' activation - an immersive bus experience touring 15 cities in São Paulo state. The interactive bus features brand experiences, museum, photo areas, and product customization workshops.
• Share Your SexminorGTM or Marketing PartnerPartnership with Brazil's largest women-only sexuality community (180,000+ members) for K-MED intimate lubricant brand. Includes closed event for 80 special guests and educational content about female pleasure and sexual health.
• FinicoreGTM or Marketing PartnerCo-branding partnership launching Carmed Fini lip moisturizers in flavors inspired by iconic Fini candies (Beijos, Bananas, Dentaduras). The collaboration drove massive social media engagement with 200+ million views on TikTok and Instagram.
• Mattel (Barbie)coreGTM or Marketing PartnerGlobal toy company partnership launching Carmed Barbie collection celebrating Barbie's 65th anniversary. Three flavors (Pink, Rose Gold, Crystal) with expected revenue of R$ 80 million in first days of sales.
• Pague Menos e ExtrafarmacoreChannel Partner/ Reseller/ DistributorPrimary pharmacy retail partner for product launches. Joint event for Ressaliv relaunch with pocket show by Nattan in Fortaleza. Partnership provides access to pharmacy chain present in all Brazilian states.
• SESI/Sistema FIEMGminorStrategic or Co-development PartnerPartnership for 'Programa Vuelta al Cole' (Back to School Program) offering Cimed employees opportunity to complete elementary and high school education, winning the Sindusfarma Bumerangue Award in 2011.
• Airvantis e CNPEMminorStrategic or Co-development PartnerSpace research partnership for CimedX project - first Brazilian pharmaceutical company to conduct experiments in space, testing protein crystallization aboard the International Space Station.
• Burger KingminorGTM or Marketing PartnerMarketing collaboration as part of Carmed's cross-brand partnership strategy maintaining brand presence on TikTok and Instagram trends.

Scale indicators15 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• EMS Pharma: Brazil's largest pharmaceutical company by units sold and Cimed's closest direct competitor, with a similar generics-and-OTC model, broad national distribution, and major sports marketing investments. Comparable across product mix, channel strategy, and Brazilian market positioning.
• Aché Laboratórios: Brazilian pharmaceutical company with a strong branded prescription, OTC, and dermocosmetics portfolio. Comparable to Cimed across therapeutic categories, branded prescription marketing, and Brazilian retail channel strategy.
• Eurofarma Laboratórios: Major Brazilian pharmaceutical manufacturer with strong generics, OTC, and prescription portfolios plus branded specialty products. Operates with similar vertically integrated manufacturing and national distribution, making it a comparable peer in scale, model, and market.
• Biolab Farmacêutica: Brazilian pharmaceutical manufacturer with branded prescription, OTC, and dermocosmetics lines. Comparable to Cimed across branded pharmaceutical manufacturing, dermatology/OTC focus, and Brazilian distribution.
• Hyper Pharma (Hyper Pharma S.A.): One of Brazil's largest pharmaceutical groups, formed from the Hypermarcas restructuring, with leading OTC and generics brands. Direct peer given similar scale, branded OTC/generics mix, and emphasis on mass-market Brazilian consumer health.

Broad incumbents

• Teva Pharmaceutical Industries: Global generics major with broad OTC and specialty portfolios. Comparable to Cimed's generics manufacturing and OTC business model, though globally diversified rather than Brazil-concentrated.
• Sanofi Brasil: Global pharmaceutical major with substantial Brazilian operations across prescription, OTC, vaccines, and consumer health. Comparable as a broader incumbent operating in the same Brazilian categories as Cimed but with a wider global portfolio.
• Bayer Brasil: Global life sciences incumbent with meaningful Brazilian OTC, consumer health, and prescription business (notably Aspirin, Bepantriz-Derma historical positioning). Comparable across OTC, vitamins, and personal care categories that Cimed addresses.
• GSK Brasil: Global pharmaceutical and consumer health company with Brazilian OTC, oral care, and vitamins presence. Comparable to Cimed across consumer health/OTC distribution in Brazil, though with a broader global portfolio.

Regional players

• Prati-Donaduzzi: Largest Brazilian generics manufacturer by units, family-owned with strong national distribution. Comparable to Cimed in generics manufacturing scale and Brazilian-only geographic focus, but with less consumer-brand and sports-marketing emphasis.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/user/canalgrupocimed
• Facebookfacebook.com/GrupoCimed
• LinkedInlinkedin.com/company/grupocimed
• Instagraminstagram.com/cimedremedios
• TikToktiktok.com/@cimed?lang=pt-BR

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about cimed industria de medicamentos ltda.